- Home
- AVIR vs SPIR Comparison
AVIR vs SPIR Comparison
Compare AVIR & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- SPIR
- Stock Information
- Founded
- AVIR 2012
- SPIR 2012
- Country
- AVIR United States
- SPIR United States
- Employees
- AVIR N/A
- SPIR N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- SPIR Telecommunications Equipment
- Sector
- AVIR Health Care
- SPIR Consumer Discretionary
- Exchange
- AVIR Nasdaq
- SPIR Nasdaq
- Market Cap
- AVIR 276.9M
- SPIR 238.3M
- IPO Year
- AVIR 2020
- SPIR N/A
- Fundamental
- Price
- AVIR $3.25
- SPIR $15.59
- Analyst Decision
- AVIR Hold
- SPIR Strong Buy
- Analyst Count
- AVIR 1
- SPIR 6
- Target Price
- AVIR $6.88
- SPIR $19.20
- AVG Volume (30 Days)
- AVIR 178.7K
- SPIR 376.4K
- Earning Date
- AVIR 11-07-2024
- SPIR 12-03-2024
- Dividend Yield
- AVIR N/A
- SPIR N/A
- EPS Growth
- AVIR N/A
- SPIR N/A
- EPS
- AVIR N/A
- SPIR N/A
- Revenue
- AVIR N/A
- SPIR $107,223,000.00
- Revenue This Year
- AVIR N/A
- SPIR $18.74
- Revenue Next Year
- AVIR N/A
- SPIR $23.69
- P/E Ratio
- AVIR N/A
- SPIR N/A
- Revenue Growth
- AVIR N/A
- SPIR 24.15
- 52 Week Low
- AVIR $2.81
- SPIR $4.71
- 52 Week High
- AVIR $4.60
- SPIR $19.40
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- SPIR 81.80
- Support Level
- AVIR $3.10
- SPIR $12.73
- Resistance Level
- AVIR $3.48
- SPIR $14.87
- Average True Range (ATR)
- AVIR 0.13
- SPIR 1.04
- MACD
- AVIR -0.01
- SPIR 0.40
- Stochastic Oscillator
- AVIR 29.52
- SPIR 99.81
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.